Influx Healthtech IPO - Day 3 Subscription at 201.35 Times

Influx Healthtech's initial public offering (IPO) has demonstrated exceptional investor demand through its three-day subscription period, with Influx Healthtech's stock price set at ₹96 per share and Influx Healthtech's share price expected to reflect outstanding market reception. The ₹55.63 crore IPO has witnessed remarkable progress, with subscription rates opening at 5.89 times on day one, improving to 25.47 times on day two, and reaching exceptional 201.35 times by 5:09:59 PM on the final day, demonstrating tremendous investor interest in this healthcare-focused contract manufacturing company incorporated in September 2020, operates three manufacturing facilities in Thane.

Influx Healthtech IPO non-institutional investors segment leads with phenomenal 481.10 times subscription, while qualified institutional buyers demonstrate exceptional participation at 137.87 times and retail investors show exceptional interest at 117.68 times, reflecting tremendous investor confidence in this company with diversified product portfolio including tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym/sports supplements, skin care, body care, hair care, beard care solutions, face masks, soaps, Ayurvedic/herbal formulations, veterinary feed supplements, and homecare solutions.

Influx Healthtech IPO subscription reached an exceptional 201.35 times on the final day, led by NII (481.10x), QIB (137.87x), and Retail (117.68x). Total applications reached 2,20,296.

Subscription Status of Influx Healthtech IPO:

Here are the subscription details for Influx Healthtech IPO as of Day 3 (June 20, 2025, 5:09:33 PM):

Key Highlights - Day 3:

• Overall subscription reaching an exceptional 201.35 times, massive surge from day two's 25.47 times
• NII segment leading with phenomenal demand at 481.10 times, an extraordinary jump from day two's 32.28 times
• QIB segment showing exceptional participation at 137.87 times, a remarkable increase from day two's 1.69 times
• Retail segment demonstrating exceptional interest at 117.68 times, a significant improvement from day two's 36.13 times
• Total applications reached 2,20,296, indicating massive investor participation
• The cumulative bid amount reached ₹7,844.84 crores against the issue size of ₹55.63 crores

Influx Healthtech IPO - Day 2 Subscription at 25.47 Times

Key Highlights - Day 2:

• Overall subscription improving significantly to 25.47 times, strong progress from day one's 5.89 times
• Retail segment leading with excellent demand at 36.13 times, strong improvement from day one's 8.46 times
• NII segment showing exceptional participation at 32.28 times, a significant increase from day one's 5.81 times
• QIB segment showing modest interest at 1.69 times, slight improvement from day one's 1.46 times

Influx Healthtech IPO - Day 1 Subscription at 5.89 Times

Key Highlights - Day 1:

• Overall subscription opening solid at 5.89 times, showing encouraging initial investor interest
• Retail segment leading with good early participation at 8.46 times, indicating individual investor confidence
• NII segment showing solid early interest at 5.81 times, reflecting high-net-worth confidence
• QIB segment showing modest initial participation at 1.46 times on day one
• Opening day demonstrates positive initial engagement across categories

About Influx Healthtech IPO

Incorporated in September 2020, Influx Healthtech Limited is a healthcare-focused company specialising in contract manufacturing. The company is a reliable CDMO, providing specialised services to clients in multiple industries. The company has three manufacturing facilities in Thane, Maharashtra, each covering an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.

Financial performance shows steady growth with revenue increasing 5% from ₹100.10 crores in FY2024 to ₹104.99 crores in FY2025, while profit after tax surged 19% from ₹11.22 crores to ₹13.37 crores. The company maintains excellent profitability metrics with 36.98% ROE, 49.17% ROCE, operates with a minimal debt-to-equity ratio of 0.01, and has a market capitalisation of ₹222.24 crores. Post-IPO P/E ratio of 16.63x appears reasonable for a growing healthcare manufacturing company.

Highlights of the Influx Healthtech IPO:

• IPO type: Book Building IPO
• IPO size: ₹55.63 crores
• Fresh Issue: 46.94 lakh shares (₹45.07 crores)
• Offer for Sale: 11.00 lakh shares (₹10.56 crores)
• Face value: ₹10 per share
• Issue price: ₹96 per share
• Lot size: 1,200 shares
• Minimum investment for retail investors: ₹1,15,200 (1 lot, 1,200 shares)
• Minimum investment for HNI: ₹2,30,400 (2 lots, 2,400 shares)
• Anchor investor allocation: ₹16.67 crores
• Book-running lead manager: Rarever Financial Advisors Pvt. Ltd.
• Registrar: Maashitla Securities Private Limited
• Market maker: R.K.Stock Holding Private Limited
• Listing at: NSE SME
• IPO opens: June 18, 2025
• IPO closes: June 20, 2025
• Allotment date: June 23, 2025
• Listing date: June 25, 2025
•